Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115095
Chunk: 178

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 178
---
 deemed conversion of all outstanding Series A Preferred Stock held by the Record Preferred Holder) as of the Record Date as set forth in the records of our transfer agent (with respect to the Record Common Holders and Record Preferred Holder) and ours (with respect to the Record Warrant Holders and the Record Note Holders) as of the Record Date. As of the date of this prospectus, the Board has not yet set a Payment Date for the Dividend and retains the right to revoke the Dividend and change the Record Date.**

<div align='center'>107</div>

Should we decide in the future to do so, as a holding company, our ability to pay dividends on our capital stock and meet other obligations depends upon the receipt of dividends or other payments from our operating subsidiaries. Further, our ability to pay dividends may be limited by covenants of any existing and future outstanding indebtedness we or our subsidiaries incur.

<div align='center'>108</div>

SELECTED HISTORICAL FINANCIAL DATA On April 15, 2025, we effected a 1-for-35reverse stock split of our common stock. The following selected historical financial data was derived from our historical financial statements that are included elsewhere in this prospectus, and recasts certain portions of such financial statements to give effect to the Reverse Stock Split. No other changes to our historical financial statements were made in recasting the amounts set forth below.

| Consolidated Statements of Operations Data (in thousands, except   
 shares)                                                            |     | Years Ended  
 December 31, 
 2024         
 (UNAUDITED)  |         |   |     | 2023 |          |   |
|:-------------------------------------------------------------------|:----|:-------------|--------:|:--|:----|:-----|---------:|:--|
| Revenue                                                            |     | $            |  56,590 |   |     | $    |   46,743 |   |
| Cost of revenue                                                    |     |              |  16,689 |   |     |      |   15,681 |   |
| Gross profit                                                       |     |              |  39,901 |   |     |      |   31,062 |   |
| Research and development                                           |     |              |   9,641 |   |     |      |   12,746 |   |
| Selling, general and administrative expenses                       |     |              | 119,016 |   |     |